Effect of Maternal Depression on Brain-derived Neurotrophic Factor Levels in Fetal Cord Blood
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: We aimed to assess the association between cord blood brain-derived neurotrophic factor (BDNF) concentration and maternal depression during pregnancy. Methods: A total of 48 pregnant women, admitted for elective caesarean section to Department of Obstetrics and Gynecology, The Konya Research and Training Hospital and Konya Necmettin Erbakan University Meram Medical Faculty, were included in this study. The study group included 23 women diagnosed as having depression during pregnancy and the control group included 25 pregnant women who did not experience depression during pregnancy. Results: The groups had similar sociodemographic characteristics. Cord blood BDNF concentration was significantly lower in babies born to mothers with major depression as compared with those in the control group. We didn’t find any correlation between the umbilical cord blood BDNF levels and BDI scores. Conclusion: The results suggest that the existence of major depression in pregnant women may negatively affect fetal circulating BDNF levels.
Abstract
Objective: We aimed to assess the association between cord blood brain-derived neurotrophic factor (BDNF) concentration and maternal depression during pregnancy. Methods: A total of 48 pregnant women, admitted for elective caesarean section to Department of Obstetrics and Gynecology, The Konya Research and Training Hospital and Konya Necmettin Erbakan University Meram Medical Faculty, were included in this study. The study group included 23 women diagnosed as having depression during pregnancy and the control group included 25 pregnant women who did not experience depression during pregnancy. Results: The groups had similar sociodemographic characteristics. Cord blood BDNF concentration was significantly lower in babies born to mothers with major depression as compared with those in the control group. We didn’t find any correlation between the umbilical cord blood BDNF levels and BDI scores. Conclusion: The results suggest that the existence of major depression in pregnant women may negatively affect fetal circulating BDNF levels.
참고문헌 (36)
- Camkurt MA, "Depression in pregnancy is associated with decreased glutathione peroxidase activity in fetal cord blood", J Psychiatr Res, 79, pp.57~60 (2016)
- Kitamura T, "Multicentre prospective study of perinatal depression in Japan : incidence and correlates of antenatal and postnatal depression", Arch Womens Ment Health, 9, pp.121~130 (2006)
- Felice E, "Prevalence rates and psychosocial characteristics associated with depression in pregnancy and postpartum in Maltese women", J Affect Disord, 82, pp.297~301 (2004)
- Uguz F, "Is pregnancy associated with mood and anxiety disorders? A cross-sectional study", Gen Hosp Psychiatry, 32, pp.213~215 (2010)
- Camkurt MA, "Probable preventive effects of placenta from oxidative stress; Evaluation of total antioxidant status, total oxidant status and oxidative stress index in fetal cord blood during the delivery", Psychiatry Res, 240, pp.222~225 (2016)
- Uguz F, "Epidemiology and clinical features of obsessive-compulsive disorder during pregnancy and postpartum period : A review", J Mood Disord, 1, pp.178~186 (2011)
- Suri R, "Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth", Am J Psychiatry, 164, pp.1206~1213 (2007)
- Grote NK, "A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction", Arch Gen Psychiatry, 67, pp.1012~1024 (2010)
- Lewis AJ, "Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication", Aust N Z J Psychiatry, 44, pp.482~487 (2010)
- Davalos DB, "Untreated prenatal maternal depression and the potential risks to offspring : a review", Arch Womens Ment Health, 15, pp.1~14 (2012)
- Brunoni AR, "A systematic review and meta-analysis of clinical studies on major depression and BDNF levels : implications for the role of neuroplasticity in depression", Int J Neuropsychopharmacol, 11, pp.1169~1180 (2008)
- Martinowich K, "New insights into BDNF function in depression and anxiety", Nat Neurosci, 10, pp.1089~1093 (2007)
- Sözeri-Varma G, "Relationship between serum BDNF levels and cognitive functions, cortisol levels in depressive disorder", J Mood Disord, 2, pp.58~65 (2012)
- McAllister AK, "Neurotrophins regulate dendritic growth in developing visual cortex", Neuron, 15, pp.791~803 (1995)
- Fossati P, "Neuroplasticity: from MRI to depressive symptoms", Eur Neuropsychopharmacol, 14(Suppl 5), pp.S503~S510 (2004)
- Masi G, "The hippocampus, neurotrophic factors and depression : possible implications for the pharmacotherapy of depression", CNS Drugs, 25, pp.913~931 (2011)
- Rees S, "Fetal and neonatal origins of altered brain development", Early Hum Dev, 81, pp.753~761 (2005)
- Ansorge MS, "Neurodevelopmental origins of depressive disorders", Curr Opin Pharmacol, 7, pp.8~17 (2007)
- Kodomari I, "Maternal supply of BDNF to mouse fetal brain through the placenta", Neurochem Int, 54, pp.95~98 (2009)
- Chouthai NS, "Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions", Pediatr Res, 53, pp.965~969 (2003)
- Karege F, "Decreased serum brain-derived neurotrophic factor levels in major depressed patients", Psychiatry Res, 109, pp.143~148 (2002)
- Uguz F, "Maternal generalized anxiety disorder during pregnancy and fetal brain development : a comparative study on cord blood brain-derived neurotrophic factor levels", J Psychosom Res, 75, pp.346~350 (2013)
- Uguz F, "Neuroinflammation in the fetus exposed to maternal obsessive-compulsive disorder during pregnancy : a comparative study on cord blood tumor necrosis factor-alpha levels", Compr Psychiatry, 55, pp.861~865 (2014)
- Camkurt MA, "Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naïve, first episode, non-smoker major depression patients and healthy controls", Psychiatry Res, 238, pp.81~85 (2016)
- Mehmet Güneş, "Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment", Clinical Psychopharmacology and Neuroscience, 14(4), pp.345~350 (2016), 대한정신약물학회
- Ebru Fındıklı, "The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients", Clinical Psychopharmacology and Neuroscience, 16(1), pp.88~94 (2018), 대한정신약물학회[DOI]
- Mehmet Akif Camkurt, "Evaluation of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Fetal Cord Blood of Depressed Mothers", Clinical Psychopharmacology and Neuroscience, 15(1), pp.35~39 (2017), 대한정신약물학회[DOI]
- Gerardin P, "Depression during pregnancy : is the developmental impact earlier in boys? A prospective case-control study", J Clin Psychiatry, 72, pp.378~387 (2011)
- Van den Hove DL, "Prenatal stress and neonatal rat brain development", Neuroscience, 137, pp.145~155 (2006)
- Talge NM, "Antenatal maternal stress and long-term effects on child neurodevelopment : how and why", J Child Psychol Psychiatry, 48, pp.245~261 (2007)
- CV), "Structured clinical interview for DSM-IV clinical version (SCID-I", pp.1997, First MB
- Beck AT, "An inventory for measuring clinical anxiety : psychometric properties", J Consult Clin Psychol, 56, pp.893~897 (1988)
- Fukumitsu H, "Simultaneous expression of brain-derived neurotrophic factor and neurotrophin-3 in Cajal-Retzius, subplate and ventricular progenitor cells during early development stages of the rat cerebral cortex", Neuroscience, 84, pp.115~127 (1998)
- Chan JP, "Examination of behavioral deficits triggered by targeting Bdnf in fetal or postnatal brains of mice", Neuroscience, 142, pp.49~58 (2006)
- Lee BH, "Decreased plasma BDNF level in depressive patients", J Affect Disord, 101, pp.239~244 (2007)
- Shimizu E, "Alterations of serum levels of brain-derived neurotrophic factor(BDNF)in depressed patients with or without antidepressants", Biol Psychiatry, 54, pp.70~75 (2003)
